Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors
- Publication Date:
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- OSTI Identifier:
- 1396355
- Grant/Contract Number:
- AC02-06CH11357
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Bioorganic and Medicinal Chemistry Letters
- Additional Journal Information:
- Journal Name: Bioorganic and Medicinal Chemistry Letters Journal Volume: 26 Journal Issue: 20; Journal ID: ISSN 0960-894X
- Publisher:
- Elsevier
- Country of Publication:
- United Kingdom
- Language:
- English
Citation Formats
Ladziata, Vladimir, Glunz, Peter W., Zou, Yan, Zhang, Xiaojun, Jiang, Wen, Jacutin-Porte, Swanee, Cheney, Daniel L., Wei, Anzhi, Luettgen, Joseph M., Harper, Timothy M., Wong, Pancras C., Seiffert, Dietmar, Wexler, Ruth R., and Priestley, E. Scott. Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. United Kingdom: N. p., 2016.
Web. doi:10.1016/j.bmcl.2016.08.088.
Ladziata, Vladimir, Glunz, Peter W., Zou, Yan, Zhang, Xiaojun, Jiang, Wen, Jacutin-Porte, Swanee, Cheney, Daniel L., Wei, Anzhi, Luettgen, Joseph M., Harper, Timothy M., Wong, Pancras C., Seiffert, Dietmar, Wexler, Ruth R., & Priestley, E. Scott. Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. United Kingdom. https://doi.org/10.1016/j.bmcl.2016.08.088
Ladziata, Vladimir, Glunz, Peter W., Zou, Yan, Zhang, Xiaojun, Jiang, Wen, Jacutin-Porte, Swanee, Cheney, Daniel L., Wei, Anzhi, Luettgen, Joseph M., Harper, Timothy M., Wong, Pancras C., Seiffert, Dietmar, Wexler, Ruth R., and Priestley, E. Scott. Sat .
"Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors". United Kingdom. https://doi.org/10.1016/j.bmcl.2016.08.088.
@article{osti_1396355,
title = {Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors},
author = {Ladziata, Vladimir and Glunz, Peter W. and Zou, Yan and Zhang, Xiaojun and Jiang, Wen and Jacutin-Porte, Swanee and Cheney, Daniel L. and Wei, Anzhi and Luettgen, Joseph M. and Harper, Timothy M. and Wong, Pancras C. and Seiffert, Dietmar and Wexler, Ruth R. and Priestley, E. Scott},
abstractNote = {},
doi = {10.1016/j.bmcl.2016.08.088},
journal = {Bioorganic and Medicinal Chemistry Letters},
number = 20,
volume = 26,
place = {United Kingdom},
year = {Sat Oct 01 00:00:00 EDT 2016},
month = {Sat Oct 01 00:00:00 EDT 2016}
}
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1016/j.bmcl.2016.08.088
https://doi.org/10.1016/j.bmcl.2016.08.088
Other availability
Search WorldCat to find libraries that may hold this journal
Cited by: 5 works
Citation information provided by
Web of Science
Web of Science
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Cyclopropylboronic acid: synthesis and Suzuki cross-coupling reactions
journal, September 2002
- Wallace, Debra J.; Chen, Cheng-yi
- Tetrahedron Letters, Vol. 43, Issue 39
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
journal, April 2011
- He, Kan; Luettgen, Joseph M.; Zhang, Donglu
- European Journal of Drug Metabolism and Pharmacokinetics, Vol. 36, Issue 3
On the size of the active site in proteases. I. Papain
journal, April 1967
- Schechter, Israel; Berger, Arieh
- Biochemical and Biophysical Research Communications, Vol. 27, Issue 2, p. 157-162
Potent 4-amino-5-azaindole factor VIIa inhibitors
journal, September 2006
- Hu, Huiyong; Kolesnikov, Aleksandr; Riggs, Jennifer R.
- Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 17
Discovery of the Novel Antithrombotic Agent 5-Chloro- N -({(5 S )-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor
journal, September 2005
- Roehrig, Susanne; Straub, Alexander; Pohlmann, Jens
- Journal of Medicinal Chemistry, Vol. 48, Issue 19
Entering the Era of Non-Basic P1 Site Groups: Discovery of Xarelto™ (Rivaroxaban)
journal, February 2010
- Straub, Alexander; Roehrig, Susanne; Hillisch, Alexander
- Current Topics in Medicinal Chemistry, Vol. 10, Issue 3
Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors
journal, July 2015
- Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati
- Journal of Medicinal Chemistry, Vol. 58, Issue 15
Pros and cons of new oral anticoagulants
journal, December 2013
- Bauer, Kenneth A.
- Hematology, Vol. 2013, Issue 1
Copper/Amino Acid Catalyzed Cross-Couplings of Aryl and Vinyl Halides with Nucleophiles †
journal, November 2008
- Ma, Dawei; Cai, Qian
- Accounts of Chemical Research, Vol. 41, Issue 11
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors
journal, May 2015
- Glunz, Peter W.; Cheng, Xuhong; Cheney, Daniel L.
- Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 10
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.
journal, April 1998
- Mueller, B. M.; Ruf, W.
- Journal of Clinical Investigation, Vol. 101, Issue 7
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
journal, December 2010
- Perzborn, Elisabeth; Roehrig, Susanne; Straub, Alexander
- Nature Reviews Drug Discovery, Vol. 10, Issue 1
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
journal, April 2012
- De Caterina, Raffaele; Husted, Steen; Wallentin, Lars
- Journal of the American College of Cardiology, Vol. 59, Issue 16
Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
journal, July 2014
- Bounameaux, Henri; Camm, A. John
- Drugs, Vol. 74, Issue 11
Assessment of Bleeding Propensity in Non-Human Primates by Combination of Selective Tissue Factor/VIIa Inhibition and Aspirin Compared to Warfarin and Aspirin Treatment
journal, January 2004
- Salyers, Anita K.; Szalony, James A.; Suleymanov, Osman D.
- Pharmacology, Vol. 70, Issue 2
Active Site Inhibited Factor VIIa (DEGR VIIa) Attenuates the Coagulant and Interleukin-6 and -8, but not Tumor Necrosis Factor, Responses of the Baboon to LD100Escherichia coli
journal, March 1998
- Taylor, F. B.; Chang, A. C. K.; Peer, G.
- Blood, Vol. 91, Issue 5
Dimethylsulfoxonium Methylide
journal, March 1962
- Corey, E. J.; Chaykovsky, Michael.
- Journal of the American Chemical Society, Vol. 84, Issue 5
Copper-Catalyzed Synthesis of Primary Arylamines via Cascade Reactions of Aryl Halides with Amidine Hydrochlorides
journal, July 2008
- Gao, Xiaoting; Fu, Hua; Qiao, Renzhong
- The Journal of Organic Chemistry, Vol. 73, Issue 17
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
journal, February 2006
- Steffel, Jan; Lüscher, Thomas F.; Tanner, Felix C.
- Circulation, Vol. 113, Issue 5
Atropisomer Control in Macrocyclic Factor VIIa Inhibitors
journal, November 2015
- Glunz, Peter W.; Mueller, Luciano; Cheney, Daniel L.
- Journal of Medicinal Chemistry, Vol. 59, Issue 8
Tissue factor–fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic
journal, September 2014
- Priestley, E. Scott
- Drug Discovery Today, Vol. 19, Issue 9
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity
journal, August 2006
- Zbinden, Katrin Groebke; Banner, David W.; Hilpert, Kurt
- Bioorganic & Medicinal Chemistry, Vol. 14, Issue 15
Nonbenzamidine acylsulfonamide tissue factor–factor VIIa inhibitors
journal, September 2013
- Glunz, Peter W.; Zhang, Xiaojun; Zou, Yan
- Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18
Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model
journal, June 2003
- Suleymanov, Osman D.; Szalony, James A.; Salyers, Anita K.
- Journal of Pharmacology and Experimental Therapeutics, Vol. 306, Issue 3
The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor
journal, January 2006
- Arnold, C. Shane; Parker, Cynthia; Upshaw, Ramanda
- Thrombosis Research, Vol. 117, Issue 3
Redefining medical treatment in the management of unstable angina
journal, January 2000
- Braunwald, Eugene; Califf, Robert M.; Cannon, Christopher P.
- The American Journal of Medicine, Vol. 108, Issue 1
Dimethyloxosulfonium Methylide ((CH 3 ) 2 SOCH 2 ) and Dimethylsulfonium Methylide ((CH 3 ) 2 SCH 2 ). Formation and Application to Organic Synthesis
journal, March 1965
- Corey, E. J.; Chaykovsky, Michael
- Journal of the American Chemical Society, Vol. 87, Issue 6
The Pharmacology and Management of the Vitamin K Antagonists
journal, September 2004
- Ansell, Jack; Hirsh, Jack; Poller, Leon
- Chest, Vol. 126, Issue 3
Dimethylsulfonium Methylide, a Reagent for Selective Oxirane Synthesis from Aldehydes and Ketones
journal, October 1962
- Corey, E. J.; Chaykovsky, Michael.
- Journal of the American Chemical Society, Vol. 84, Issue 19
Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleeding
journal, August 2013
- Nagakura, Tadashi; Tabata, Kimiyo; Kira, Kazunobu
- Thrombosis Research, Vol. 132, Issue 2
Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time
journal, January 2003
- Szalony, James A.; Suleymanov, Osman D.; Salyers, Anita K.
- Thrombosis Research, Vol. 112, Issue 3
The Discovery and Development of Angiotensin II Antagonists
book, January 1998
- Carini, David J.; Christ, David D.; Duncia, John V.
- Integration of Pharmaceutical Discovery and Development. Pharmaceutical Biotechnology
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology
journal, July 2004
- Cushman, Mary; Tsai, Albert W.; White, Richard H.
- The American Journal of Medicine, Vol. 117, Issue 1
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors
journal, December 2013
- Zhang, Xiaojun; Jiang, Wen; Jacutin-Porte, Swanee
- ACS Medicinal Chemistry Letters, Vol. 5, Issue 2
Dabigatran etexilate
journal, July 2008
- Eriksson, Bengt I.; Smith, Helen; Yasothan, Uma
- Nature Reviews Drug Discovery, Vol. 7, Issue 7
Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
journal, November 2010
- Petrillo, Gianluca; Cirillo, Plinio; Luana D'Ascoli, Greta-
- Current Cardiology Reviews, Vol. 6, Issue 4
Inhibition of Arterial Thrombosis by a Soluble Tissue Factor Mutant and Active Site-blocked Factors IXa and Xa in the Guinea Pig
journal, January 2001
- Himber, Jacques; Refino, Canio; Burcklen, Louis
- Thrombosis and Haemostasis, Vol. 85, Issue 03
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1 H -pyrazolo[3,4- c ]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa
journal, November 2007
- Pinto, Donald J. P.; Orwat, Michael J.; Koch, Stephanie
- Journal of Medicinal Chemistry, Vol. 50, Issue 22
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
journal, May 2000
- Camerer, E.; Huang, W.; Coughlin, S. R.
- Proceedings of the National Academy of Sciences, Vol. 97, Issue 10
Discovery of Novel P1 Groups for Coagulation Factor VIIa Inhibition Using Fragment-Based Screening
journal, February 2015
- Cheney, Daniel L.; Bozarth, Jeffrey M.; Metzler, William J.
- Journal of Medicinal Chemistry, Vol. 58, Issue 6
An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion
journal, February 2008
- McNaney, Colleen A.; Drexler, Dieter M.; Hnatyshyn, Serhiy Y.
- ASSAY and Drug Development Technologies, Vol. 6, Issue 1
Dissociation of Antithrombotic Effect and Bleeding Time Prolongation in Rabbits by Inhibiting Tissue Factor Function
journal, January 1997
- Himber, Jacques; Kirchhofer, Daniel; Riederer, Markus
- Thrombosis and Haemostasis, Vol. 78, Issue 03
New anticoagulants: From bench to bedside
journal, January 2007
- Haas, S.; Schellong, S.
- Hämostaseologie, Vol. 27, Issue 01
Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores
journal, June 2009
- Kotian, Pravin L.; Krishnan, Raman; Rowland, Scott
- Bioorganic & Medicinal Chemistry, Vol. 17, Issue 11
Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands
journal, January 2007
- Miura, Masanori; Seki, Norio; Koike, Takanori
- Bioorganic & Medicinal Chemistry, Vol. 15, Issue 1
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex
journal, March 2016
- Zhang, Xiaojun; Glunz, Peter W.; Johnson, James A.
- Journal of Medicinal Chemistry, Vol. 59, Issue 15
BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies
journal, January 2010
- Wong, Pancras; Luettgen, Joseph; Rendina, Alan
- Thrombosis and Haemostasis, Vol. 104, Issue 08
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
journal, April 2002
- Hauel, Norbert H.; Nar, Herbert; Priepke, Henning
- Journal of Medicinal Chemistry, Vol. 45, Issue 9
Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model
journal, April 2006
- Young, Wendy B.; Mordenti, Joyce; Torkelson, Steven
- Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 7
Coagulation proteases and human cancer
journal, April 2002
- Sampson, M. T.; Kakkar, A. K.
- Biochemical Society Transactions, Vol. 30, Issue 2
Tissue Factor–Activated Coagulation Cascade in the Tumor Microenvironment Is Critical for Tumor Progression and an Effective Target for Therapy
journal, August 2011
- Liu, Yuan; Jiang, Pengfei; Capkova, Katerina
- Cancer Research, Vol. 71, Issue 20
Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial Thrombosis
journal, January 1998
- Golino, Paolo; Ragni, Massimo; Cirillo, Plinio
- Circulation Research, Vol. 82, Issue 1
Phase I/II study of PCI-27483, a coagulation factor VIIa (FVIIa) inhibitor, in combination with gemcitabine in patients with advanced pancreatic cancer.
journal, May 2013
- Mahesh, Sameer A.; Gabrail, Nashat Y.; Gandhi, Jitendra G.
- Journal of Clinical Oncology, Vol. 31, Issue 15_suppl
Synthetic applications and mechanism studies of the decarbalkoxylations of geminal diesters and related systems effected in dimethyl sulfoxide by water and/or by water with added salts
journal, January 1978
- Krapcho, A. Paul; Weimaster, J. F.; Eldridge, J. M.
- The Journal of Organic Chemistry, Vol. 43, Issue 1
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
journal, September 2010
- Pinto, Donald J. P.; Smallheer, Joanne M.; Cheney, Daniel L.
- Journal of Medicinal Chemistry, Vol. 53, Issue 17
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
journal, June 2008
- Lassen, Michael R.; Ageno, Walter; Borris, Lars C.
- New England Journal of Medicine, Vol. 358, Issue 26
DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles
journal, September 2008
- Furugohri, T.; Isobe, K.; Honda, Y.
- Journal of Thrombosis and Haemostasis, Vol. 6, Issue 9
Beyond heparin and warfarin: the new generation of anticoagulants
journal, February 2007
- Weitz, Jeffrey I.; Linkins, Lori-Ann
- Expert Opinion on Investigational Drugs, Vol. 16, Issue 3
A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo
journal, March 2005
- Olivero, Alan G.; Eigenbrot, Charles; Goldsmith, Richard
- Journal of Biological Chemistry, Vol. 280, Issue 10
Advances in Anticoagulants
book, January 2017
- Quan, M. L.; Glunz, P. W.; Smallheer, J. M.
- Comprehensive Medicinal Chemistry III
Caco-2 cell permeability assays to measure drug absorption
journal, August 2005
- van Breemen, Richard B.; Li, Yongmei
- Expert Opinion on Drug Metabolism & Toxicology, Vol. 1, Issue 2